162. Duties of Inspectors specially authorised to inspect to manufacture of Ayurvedic (including Siddha) or Unani drugs. - Subject to the instruction of the controlling authority, it shall be the duty of an Inspector authorised to inspect the manufacture of Ayurvedic (including Siddha) or Unani drugs:-

i). To inspect not less than twice a year, all premises licensed for manufacture of Ayurvedic (including Siddha) or Unani drugs within the area allotted to him and to satisfy himself that the conditions of the license and the provisions of the Act and the rules made thereunder are being observed;

ii). To sent forthwith to the controlling authority after each inspection a detailed report indicating whether or not the conditions of the license and the provisions of the Act and the rules made thereunder are being observed;

iii). To take samples of the drugs manufactured on the premises and send them for test or analysis in accordance with these rules;

iv). To institute prosecutions in respect of violation of the Act and the rules made thereunder.

163. Procedure for dispatch of sample to Government Analyst and its receipt by the Government Analyst (1) Sample for test or analysis shall be sent to the Govt. Analyst by registered post or by hand in a sealed package, enclosed together with a memorandum in Form 18-A in an outer cover addressed to the Govt. Analyst.

1. The package as well as the outer cover shall be marked with a distinguishing number.

2. A copy of the memorandum and specimen impression of the seal used to seal the package shall be sent by registered post or by hand to the Govt. Analyst.

3. On receipt of the package from an Inspector, the Govt. Analyst or an Officer authorised by him in writing in this behalf shall open the package and shall also record the conditions of the seals on the package.

4. After the test or analysis has been completed, one copy of the results of the test or analysis shall be supplied forthwith to the sender in Form 13-A. A copy of the result in Form 13-A shall be sent simultaneously to the controlling authority and to the Drugs Controller, India.